BioMarin Pharmaceutical Inc.
DE ˙ DB ˙ US09061G1013
46,89 € ↓ -2,21 (-4,50%)
2026-06-02
AKTIENPREIS
SecurityDE:BM8 / BioMarin Pharmaceutical Inc.
InstitutionState Street Corp
Latest Disclosed Ownership7,295,079 shares
Latest Disclosed Value $ 412,099,013
State Street Corp reports 3.03% decrease in ownership of BM8 / BioMarin Pharmaceutical Inc.

On May 15, 2026 - State Street Corp filed a 13F-HR form disclosing ownership of 7,295,079 shares of BioMarin Pharmaceutical Inc. (DE:BM8) valued at $350,017,890 USD as of March 31, 2026. The entity filed a previous 13F-HR on February 13, 2026 disclosing 7,523,218 shares of BioMarin Pharmaceutical Inc.. This represents a change in shares of -3.03% during the quarter. The current value of the position is $342,066,254 USD.

Institutional Ownership: 13F and NPORT Filings

The Security and Class in the table below are shown exactly as filed by the investor. We do our best to track continuity of investments through acquisitions, and this will be reflected in the table as changes in names. In addition to descriptive data, performance of the investment is shown over time. To calculate quarterly performance, we first calculate cost basis of the shares purchased during the quarter, then use that to calculate gross profit. Quarterly return is Gross Profit / Starting Portfolio value.

Note that cost basis is calculated and stored in thousands, so small quarterly changes in shares frequently result in a cost basis of zero.

Upgrade to unlock premium data and export to Excel .

Disclosed Equity Positions (from 13F/NPORT Filings)
File
Date		 Effective
Date		Form Security Class ID Avg Price
Paid (Est)		 Reported
Shares		 ΔShares ΔShares
(%)		 Reported
Value
(x1000)		 ΔValue
(%)		 Alloc
(%)		 ΔAlloc ΔAlloc (%) Cost Basis
(x1000)		 Unrealized
Gain/Loss
(x1000)
2026-05-15 2026-03-31 13F BIOMARIN PHARMACEUTICAL COM 09061G101 7,295,079 -228,139 -3.03 412,099 -7.83 0.0142
2026-02-13 2025-12-31 13F BIOMARIN PHARMACEUTICAL COM 09061G101 7,523,218 -1,241,381 -14.16 447,105 -5.81 0.0150
2025-11-14 2025-09-30 13F BIOMARIN PHARMACEUTICAL COM 09061G101 8,764,599 -83,152 -0.94 474,691 -2.40 0.0165
2025-08-14 2025-06-30 13F BIOMARIN PHARMACEUTICAL COM 09061G101 8,847,751 384,661 4.55 486,361 -18.70 0.0182
2025-05-15 2025-03-31 13F BIOMARIN PHARMACEUTICAL COM 09061G101 8,463,090 -649,185 -7.12 598,256 -0.11 0.0247
2025-02-14 2024-12-31 13F BIOMARIN PHARMACEUTICAL COM 09061G101 9,112,275 289,161 3.28 598,936 -3.42 0.0236
2024-11-14 2024-09-30 13F BIOMARIN PHARMACEUTICAL COM 09061G101 8,823,114 -812,906 -8.44 620,177 -21.83 0.0252
2024-08-14 2024-06-30 13F BIOMARIN PHARMACEUTICAL COM 09061G101 9,636,020 2,740,805 39.75 793,334 31.73 0.0347
2024-05-15 2024-03-31 13F BIOMARIN PHARMACEUTICAL COM 09061G101 6,895,215 164,700 2.45 602,228 -7.20 0.0269
2024-02-14 2023-12-31 13F BIOMARIN PHARMACEUTICAL COM 09061G101 6,730,515 271,786 4.21 648,956 13.56 0.0316
2023-11-14 2023-09-30 13F BIOMARIN PHARMACEUTICAL COM 09061G101 6,458,729 505,045 8.48 571,468 10.74 0.0317
2023-08-14 2023-06-30 13F BIOMARIN PHARMACEUTICAL COM 09061G101 5,953,684 -112,634 -1.86 516,065 -12.51 0.0271
2023-05-15 2023-03-31 13F BIOMARIN PHARMACEUTICAL COM 09061G101 6,066,318 677,474 12.57 589,889 5.77 0.0333
2023-05-15 2022-12-31 13F/A-99 BIOMARIN PHARMACEUTICAL COM 09061G101 5,388,844 110,406 2.09 557,691 24.64 0.0328
2023-05-15 2022-12-31 13F BIOMARIN PHARMACEUTICAL COM 09061G101 5,388,844 110,406 557,691 0.0328
2022-11-15 2022-09-30 13F BIOMARIN PHARMACEUTICAL COM 09061G101 5,278,438 -117,928 -2.19 447,453 0.06 0.0283
2022-08-15 2022-06-30 13F BIOMARIN PHARMACEUTICAL COM 09061G101 5,396,366 15,973 0.30 447,197 7.80 0.0268
2022-05-16 2022-03-31 13F BIOMARIN PHARMACEUTICAL COM 09061G101 5,380,393 64,300 1.21 414,828 -11.68 0.0205
2022-02-14 2021-12-31 13F BIOMARIN PHARMACEUTICAL COM 09061G101 5,316,093 278,628 5.53 469,677 20.63 0.0223
2021-11-15 2021-09-30 13F BIOMARIN PHARMACEUTICAL COM 09061G101 5,037,465 130,408 2.66 389,346 -4.91 0.0206
2021-08-16 2021-06-30 13F BIOMARIN PHARMACEUTICAL COM 09061G101 4,907,057 232,655 4.98 409,445 16.00 0.0216
2021-07-09 2021-03-31 13F/A-1 BIOMARIN PHARMACEUTICAL COM 09061G101 4,674,402 -285,377 -5.75 352,964 -18.84 0.0202
2021-05-17 2021-03-31 13F BIOMARIN PHARMACEUTICAL COM 09061G101 4,674,402 -285,377 352,964 0.0202
2021-02-16 2020-12-31 13F BIOMARIN PHARMACEUTICAL COM 09061G101 4,959,779 67,978 1.39 434,923 16.86 0.0266
2020-11-10 2020-09-30 13F BIOMARIN PHARMACEUTICAL COM 09061G101 4,891,801 -254,700 -4.95 372,168 -41.37 0.0254
2020-08-14 2020-06-30 13F BIOMARIN PHARMACEUTICAL COM 09061G101 5,146,501 -393,044 -7.10 634,769 35.61 0.0461
2020-06-19 2020-03-31 13F/A-1 BIOMARIN PHARMACEUTICAL COM 09061G101 5,539,545 628,230 12.79 468,092 12.72 0.0409
2020-05-11 2020-03-31 13F BIOMARIN PHARMACEUTICAL COM 09061G101 5,539,545 628,230 468,092 41,107.9027
2020-02-06 2019-12-31 13F BIOMARIN PHARMACEUTICAL COM 09061G101 4,911,315 35,533 0.73 415,252 26.36 0.0284
2019-11-14 2019-09-30 13F BIOMARIN PHARMACEUTICAL COM 09061G101 4,875,782 186,442 3.98 328,628 -18.18 0.0245
2019-08-14 2019-06-30 13F BIOMARIN PHARMACEUTICAL COM 09061G101 4,689,340 53,188 1.15 401,642 -2.47 0.0299
2019-05-15 2019-03-31 13F BIOMARIN PHARMACEUTICAL COM 09061G101 4,636,152 738,589 18.95 411,829 24.09 0.0321
2019-02-12 2018-12-31 13F BIOMARIN PHARMACEUTICAL COM 09061G101 3,897,563 -38,806 -0.99 331,877 -13.05 0.0302
2018-11-09 2018-09-30 13F BIOMARIN PHARMACEUTICAL Common equity shares 09061G101 3,936,369 133,232 3.50 381,700 6.54 0.0293
2018-08-14 2018-06-30 13F BIOMARIN PHARMACEUTICAL Common equity shares 09061G101 3,803,137 -220,199 -5.47 358,261 9.84 0.0299
2018-05-15 2018-03-31 13F BIOMARIN PHARMACEUTICAL Common equity shares 09061G101 4,023,336 28,761 0.72 326,173 -8.43 0.0277
2018-02-14 2017-12-31 13F BIOMARIN PHARMACEUTICAL Common equity shares 09061G101 3,994,575 -19,693 -0.49 356,207 -4.66 0.0286
2017-11-14 2017-09-30 13F BIOMARIN PHARMACEUTICAL Common equity shares 09061G101 4,014,268 118,018 3.03 373,623 5.59 0.0322
2017-08-14 2017-06-30 13F BIOMARIN PHARMACEUTICAL Common equity shares 09061G101 3,896,250 -105,279 -2.63 353,854 0.74 0.0313
2017-05-15 2017-03-31 13F BIOMARIN PHARMACEUTICAL Common equity shares 09061G101 4,001,529 258,417 6.90 351,249 13.27 0.0313
2017-02-09 2016-12-31 13F BIOMARIN PHARMACEUTICAL Common equity shares 09061G101 3,743,112 108,065 2.97 310,094 -7.80 0.0292
2017-01-13 2016-09-30 13F/A-1 BIOMARIN PHARMACEUTICAL Common equity shares 09061G101 3,635,047 286,010 8.54 336,320 29.08 0.0339
2016-11-14 2016-09-30 13F BIOMARIN PHARMACEUTICAL Common equity shares 09061G101 3,620,028 334,931
2016-08-12 2016-06-30 13F BIOMARIN PHARMACEUTICAL Common equity shares 09061G101 3,349,037 62,294 1.90 260,556 -3.88 0.0280
2016-05-20 2016-03-31 13F/A-1 BIOMARIN PHARMACEUTICAL Common equity shares 09061G101 3,286,743 175,733 5.65 271,074 -16.83 0.0293
2016-05-12 2016-03-31 13F BIOMARIN PHARMACEUTICAL Common equity shares 09061G101 3,286,743 271,074
2016-02-16 2015-12-31 13F BIOMARIN PHARMACEUTICAL Common equity shares 09061G101 3,111,010 4,083 0.13 325,911 -0.40 0.0356
2015-11-16 2015-09-30 13F BIOMARIN PHARMACEUTICAL Common equity shares 09061G101 3,106,927 272,434 9.61 327,221 -15.61 0.0381
2015-08-13 2015-06-30 13F BIOMARIN PHARMACEUTICAL Common equity shares 09061G101 2,834,493 20,329 0.72 387,747 10.56 0.0414
2015-05-15 2015-03-31 13F BIOMARIN PHARMACEUTICAL Common equity shares 09061G101 2,814,164 158,546 5.97 350,700 46.09 0.0360
2015-02-11 2014-12-31 13F BIOMARIN PHARMACEUTICAL Common equity shares 09061G101 2,655,618 -1,302,679 -32.91 240,057 -15.96 0.0239
2014-11-12 2014-09-30 13F/A-1 BIOMARIN PHARMACEUTICAL Common equity shares 09061G101 3,958,297 -359,784 -8.33 285,636 6.33 0.0307
2014-11-10 2014-09-30 13F BIOMARIN PHARMACEUTICAL Common equity shares 09061G101 3,958,297 285,636
2014-08-12 2014-06-30 13F BIOMARIN PHARMACEUTICAL Common equity shares 09061G101 4,318,081 426,323 10.95 268,629 1.20 0.0290
2014-05-15 2014-03-31 13F/A-1 BIOMARIN PHARMACEUTICAL Common equity shares 09061G101 3,891,758 706,677 22.19 265,453 18.61 0.0302
2014-05-13 2014-03-31 13F BIOMARIN PHARMACEUTICAL Common equity shares 09061G101 3,893,299 265,558
2014-02-06 2013-12-31 13F/A-1 BIOMARIN PHARMACEUTICAL Common equity shares 09061G101 3,185,081 736,150 30.06 223,806 26.54 0.0249
2014-02-06 2013-12-31 13F BIOMARIN PHARMACEUTICAL Common equity shares 09061G101 1,992,430 98,127
2013-11-12 2013-09-30 13F BIOMARIN PHARMACEUTICAL Common Stock 09061G101 2,448,931 -666,175 -21.39 176,862 1.77 0.0218
2013-08-08 2013-06-30 13F BIOMARIN PHARMACEUTICAL Common Stock 09061G101 3,115,106 3,115,106 173,790 0.0227
Legend
Shares
The total number of shares held by the institution at the end of the reporting period (the effective date). This is provided in the filing.
Value
The total value of the shares as of the effective date. This is provided in the filing.
Avg. Share Price
The weighted average share price of the shares held by the institution. We use FIFO accounting to determine this price
Class
This is the security class as indicated by the filer. There are a variety of values for this field. Common values include "EC" = equity common, "EP" - equity preferred
Allocation (%)
The percent of the institution's portfolio that this position represents. This is provided in NPORT filings. For 13F filings, we calculate it.
Change in Allocation
The change in allocation from the prior reporting period. This is calculated as current allocation - prior allocation.
Change in Allocation (%)
The percent change in allocation from the prior reporting period. This is calculated as (current allocation - prior allocation) / prior allocation.
Cost Basis
The total cost of the shares held. This is calculated as reported shares * avg. share price
Unrealized Gain/Loss
This is the market value of the position as of the effective date minus the cost basis.